YM-53601 free base is a squalene synthetase inhibitor that inhibits fatty acid and lipid biosynthesis in rodents; it suppresses cholesterol biosynthesis from acetate in rat plasma in a dose-dependent manner; it reduces elevated plasma triglyceride levels in hamsters induced by protamine sulfate (an inhibitor of lipoprotein lipase that increases VLDL triglyceride levels); it also lowers elevated plasma triglyceride and cholesterol levels in Triton WR1339-treated hamsters (which inhibits VLDL degradation); and it significantly decreases plasma cholesterol levels within 1 hour after a single oral administration in hamsters fed a normal diet.